Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Methotrexate × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 5 Lymphoma 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Shwachman-Diamond Syndrome 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Leukemia 1 Hydatidiform Mole 1 Hemoglobinuria, Paroxysmal 1 Gestational Trophoblastic Disease 1 Down Syndrome 1 Congenital amegakaryocytic thrombocytopenia 1 Carcinoma, Transitional Cell 1

Interventions

Dexamethasone 56 Lenalidomide 36 daratumumab 34 Bortezomib 26 pomalidomide 22 carfilzomib 20 Cyclophosphamide 20 Calcium Dobesilate 20 Biopsy 18 Specimen Handling 17 Magnetic Resonance Spectroscopy 15 talquetamab 14 fludarabine 13 iberdomide 11 dexamethasone acetate 9 dexamethasone 21-phosphate 9 auricularum 9 selinexor 8 isatuximab 8 trametinib 6 fludarabine phosphate 6 tocilizumab 4 dabrafenib 4 belantamab mafodotin 4 nirogacestat 3 elotuzumab 3 X-Rays 3 Whole-Body Irradiation 3 Sunitinib 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04960579 2026-03-13

MM

Poseida Therapeutics, Inc.

Phase 1 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡